Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Somner, A. & Angel, J. A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. Br J Dis Chest 75, 141–153 (1981).
2. East African/British Medical Research Councils. Controlled Clinical Trial of Four Short-Course (6-Month) Regimens of Pulmonary Tuberculosis: Third Report. Lancet 304, 237–240 (1974).
3. Scorpio, A. & Zhang, Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2, 662–667 (1996).
4. Stoffels, K., Mathys, V., Fauville-Dufaux, M., Wintjens, R. & Bifani, P. Systematic Analysis of Pyrazinamide-Resistant Spontaneous Mutants and Clinical Isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 56, 5186–5193 (2012).
5. Dessau, F. I., Yeager, R. L., Burger, F. J. & Williams, J. H. Pyrazinamide (aldinamide) in experimental tuberculosis of the guinea pig. Am Rev Tuberc 65, 519–522 (1952).
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献